To understand how cancer cells carrying p53 mutants respond to anticancer drugs so as to gain resistance, we investigated whether the introduction of GCS confers cancer drug resistance, and further, identified GCS-responsive genes that contribute to anti-apoptosis in p53-mutant-carrying cancer cells. Here, TP53 is linked to cancer.